臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

关于TAIR
	计画说明

浏览
	典藏机构
	作者
	题名
	日期
	统计图表
	机构即时统计
	学术趋势

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作权
	出版社及期刊政策查询
	TAIR著作权会议记录

相关连结
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"tsou hh"的相关文件

回到依作者浏览
依题名排序	依日期排序

显示项目 41-90 / 109 (共3页)
1 2 3 > >>
每页显示[10|25|50]项目

机构	日期	题名	作者
國家衛生研究院	2017-11	Deficiency in VHR/DUSP3, a suppressor of focal adhesion kinase, reveals its role in regulating cell adhesion and migration	Chen, YR;Chou, HC;Yang, CH;Chen, HY;Liu, YW;Lin, TY;Yeh, CL;Chao, WT;Tsou, HH;Chuang, HC;Tan, TH
國家衛生研究院	2017-09	A tolerance interval approach to assessing the biosimilarity of follow-on biologics	Chen, CT;Tsou, HH;Hsiao, CF;Lai, YH;Chang, WJ;Liu, JT
國家衛生研究院	2017-03-30	Pharmacogenomics study on cadherin 2 network with regard to HIV infection and methadone treatment outcome	Kuo, HW;Shih, CL;Tsung, JH;Liu, SW;Chu, SK;Yang, HC;Tsou, HH;Wang, ZH;Chen, AC;Liu, YL
國家衛生研究院	2017-02	Integrated care for geriatric frailty and sarcopenia: A randomized control trial	Chan, DCD;Tsou, HH;Chang, CB;Yang, RS;Tsauo, JY;Chen, CY;Hsiao, CF;Hsu, YT;Chen, CH;Chang, SF;Hsiung, CA;Kuo, KN
國家衛生研究院	2017-02	A phase II trial of modified gemcitabine plus S-1 combination as the first-line treatment in patients with advanced biliary tract cancer	Chiang, NJ;Chen, JS;Chen, MH;Yang, SH;Hsu, C;Yen, CJ;Tsou, HH;Shan, YS;Chen, LT
國家衛生研究院	2017	Prediction of hepatitis B virus reactivation in lymphoma patients with resolved hepatitis B virus infection who received rituximab-containing chemotherapy: The roles of antiHBc/antiHBs quantification	Yang, HC;Tsou, HH;Pei, SN;Chang, CS;Chen, JH;Yao, M;Lin, SJ;Lin, J;Liu, TW;Chen, PJ;Cheng, AL;Hsu, C;Group, Taiwan Cooperative Oncology
國家衛生研究院	2016-11-11	Assessing benefit and consistency of treatment effect under a discrete random effects model in multiregional clinical trials	Liu, JT;Chen, CT;Lan, KKG;Tzeng, CS;Hsiao, CF;Tsou, HH
國家衛生研究院	2016-07	Long-term clinical outcome in nasopharyngeal carcinoma patients with post-radiation persistently detectable plasma EBV DNA	Wang, WY;Lin, TY;Twu, CW;Tsou, HH;Lin, PJ;Liu, YC;Huang, JW;Hsieh, HY;Lin, JC
國家衛生研究院	2016-07	GLK/MAP4K3 overexpression associates with recurrence risk for non-small cell lung cancer	Hsu, CP;Chuang, HC;Lee, MC;Tsou, HH;Lee, LW;Li, JP;Tan, TH
國家衛生研究院	2016-06	Assessing the consistency of the treatment effect under the discrete random effects model in multiregional clinical trials	Liu, JT;Tsou, HH;Gordon Lan, KK;Chen, CT;Lai, YH;Chang, WJ;Tzeng, CS;Hsiao, CF
國家衛生研究院	2016-05-03	Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer	Chiang, NJ;Hsu, C;Chen, JS;Tsou, HH;Shen, YY;Chao, Y;Chen, MH;Yeh, TS;Shan, YS;Huang, SF;Chen, LT
國家衛生研究院	2016-04-21	The discrete random-effects model-assessing benefit and consistency of treatment effect	Tsou, HH;Lan, KKG;Liu, JT;Hsiao, CF
國家衛生研究院	2015-09-01	Chemokine IP-10 is correlated with cardiac responses and status of infection with HIV and HCV in methadone maintenance patients	Liu, SW;Liu, YL;Hwang, LL;Wang, SC;Kuo, HW;Wu, SL;Dai, YWE;Liu, SC;Ho, IK;Chen, ACH;Hsiao, CF;Tsou, HH
國家衛生研究院	2015-05	A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer	Chen, JS;Hsu, C;Chiang, NJ;Tsai, CS;Tsou, HH;Huang, SF;Bai, LY;Chang, IC;Shiah, HS;Ho, CL;Yen, CJ;Lee, KD;Chiu, CF;Rau, KM;Yu, MS;Yang, Y;Hsieh, RK;Chang, JY;Shan, YS;Chao, Y;Chen, LT
國家衛生研究院	2015-04	Long-term outcome of chemotherapy-induced HBV reactivation in lymphoma patients with resolved HBV infection	Yang, HC;Tsou, HH;Chuang, MH;Chen, CL;Liu, TW;Chen, PJ;Cheng, AL;Hsu, C
國家衛生研究院	2014-06	Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study	Hsu, C;Tsou, HH;Lin, SJ;Wang, MC;Yao, M;Hwang, WL;Kao, WY;Chiu, CF;Lin, SF;Lin, J;Chang, CS;Tien, HF;Liu, TW;Chen, PJ;Cheng, AL
國家衛生研究院	2014-04	The association of genetic polymorphisms in the kappa-opioid receptor 1 gene with body weight, alcohol use, and withdrawal symptoms in patients with methadone maintenance	Wang, SC;Tsou, HH;Chung, RH;Chang, YS;Fang, CP;Chen, CH;Ho, IK;Kuo, HW;Liu, SC;Shih, YH;Wu, HY;Huang, BH;Lin, KM;Chen, AC;Hsiao, CF;Liu, YL
國家衛生研究院	2014-04	Prevention of chemotherapy-induced hbv-related hepatitis flare in lymphoma patients with resolved hbv infection: Cost analysis	Tsou, HH;Yang, HC;Chuang, MH;Wu, HY;Hsu, YT;Chang, WJ;Hsiao, CF;Hsu, C;Grp, Taiwan Cooperative Oncology
國家衛生研究院	2014-01	Establishing non-inferiority of a new treatment in a three-arm trial: Apply a step-down hierarchical model in a papulopustular acne study and an oral prophylactic antibiotics study	Liu, JT;Tzeng, CS;Tsou, HH
國家衛生研究院	2014-01	Impact of ROS1, ALK, and/or MET expression level on the therapeutic efficacy of GEMOX with and without cetuximab in ABTC: A post hoc analysis of a randomized phase II trial	Chiang, NJ;Hsu, C;Chen, JS;Tsou, HH;Chao, Y;Shan, YS;Huang, SF;Chiu, CF;Lee, KD;Chen, LT
國家衛生研究院	2013-12	Pharmacogenomics study in a Taiwanese methadone maintenance cohort	Wang, SC;Tsou, HH;Ho, IK;Lin, KM;Liu, YL
國家衛生研究院	2013-11	A 12-Year ecological study of hip fracture rates among older Taiwanese adults	Chan, DC;Lee, YS;Wu, YJ;Tsou, HH;Chen, CT;Hwang, JS;Tsai, KS;Yang, RS
國家衛生研究院	2013-11	Comparison of escitalopram and paroxetine in the treatment of major depressive disorder	Lin, HL;Hsu, YT;Liu, CY;Chen, CH;Hsiao, MC;Liu, YL;Shen, WW;Hsiao, CF;Liu, SI;Chang, LH;Tang, HS;Lai, HL;Lin, PS;Lin, KM;Tsou, HH
國家衛生研究院	2013-09	Functional genetic polymorphisms in CYP2C19 Gene in relation to cardiac side effects and treatment dose in a methadone maintenance cohort	Wang, SC;Ho, IK;Tsou, HH;Liu, SW;Hsiao, CF;Chen, CH;Tan, HK;Lin, L;Wu, CS;Su, LW;Huang, CL;Yang, YH;Liu, ML;Lin, KM;Liu, SC;Wu, HY;Kuo, HW;Chen, AC;Chang, YS;Liu, YL
國家衛生研究院	2013-08-19	A consistency approach for evaluation of biosimilar products	Tsou, HH;Chang, WJ;Hwang, WS;Lai, YH
國家衛生研究院	2013-07-23	Hepatitis C Virus infection influences the S-methadone metabolite plasma concentration	Wu, SL;Wang, SC;Tsou, HH;Kuo, HW;Ho, IK;Liu, SW;Hsu, YT;Chang, YS;Liu, YL
國家衛生研究院	2013-07	CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactions	Kuo, HW;Liu, SC;Tsou, HH;Liu, SW;Lin, KM;Lu, SC;Hsiao, MC;Hsiao, CF;Liu, CY;Chen, CH;Lu, ML;Shen, WW;Tang, HS;Liu, SI;Chang, LH;Wu, HY;Chang, YS;Yeh, TK;Chen, AC;Liu, YL
國家衛生研究院	2013-06-27	Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance	Chang, KY;Tsai, SY;Chen, SH;Tsou, HH;Yen, CJ;Liu, KJ;Fang, HL;Wu, HC;Chuang, BF;Chou, SW;Tang, CK;Liu, SY;Lu, PJ;Yen, CY;Chang, JY
國家衛生研究院	2013-05	KRAS mutation status-stratified randomized phase II trial of GEMOX with and without cetuximab in advanced biliary tract cancer (ABTC): The TCOG T1210 trial	Chen, LT;Chen, JS;Chao, Y;Tsai, CS;Shan, YS;Hsu, C;Huang, SF;Tsou, HH;Lee, KD;Chiu, CF;Rau, KM;Ho, CL;Yu, MS;Taiwan Cooperative Oncology Group
國家衛生研究院	2013-04	Comparing multiple testing correction methods between two softwares for single nucleotide polymorphisms association analyses: Using OPRD1 and diastolic blood pressure in methadone maintenance patients as an example	Chang, YS;Tsou, HH;Wang, SC;Fang, CP;Liu, YL;Ho, IK
國家衛生研究院	2013-04	EGFR variant III act as the major determinant factors in the EGFR/PI3K/AKT pathway for the survival outcome of oral cancer patients	Chang, KY;Tsai, SY;Chen, SH;Tsou, HH;Yen, CJ;Tang, CK;Yen, CY;Chang, JY
國家衛生研究院	2013-02	OPRM1 genetic polymorphisms are associated with the plasma nicotine metabolite cotinine concentration in methadone maintenance patients: A cross sectional study	Chen, YT;Tsou, HH;Kuo, HW;Fang, CP;Wang, SC;Ho, IK;Chang, YS;Chen, CH;Hsiao, CF;Wu, HY;Lin, KM;Chen, ACH;Tsai-Wu, JJ;Liu, YL
臺北醫學大學	2013	Dissecting the EGFR-P13K-AKT pathway in oral cancer highlights the roles of the EGFR variant III and its clinical relevance	Chang, KY;Tsia, SY;Chen, SH;Tsou, HH;Yen, CJ;Liu, KJ;Fang, HL;Wu, HC;Chuang, BF;Chou, SW;Tang, CK;Liu, SY;Lu, PJ;Yen, CY;chang, JY
臺北醫學大學	2013	CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactions	Kuo, HW;Liu, SC;Tsou, HH;Liu, SW;Lin, KM;Lu, SC;Hsiao, MC;Hsiao, CF;Liu, CY;Chen, CH;Lu, ML;Shen, WW;Tang, HS;Liu, SI;Chang, LH;Wu, HY;Chang
國家衛生研究院	2012-10	Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients	Wang, SC;Tsou, HH;Chen, CH;Chen, YT;Ho, IK;Hsiao, CF;Chou, SY;Lin, YF;Fang, KC;Huang, CL;Su, LW;Fang, YC;Liu, ML;Wu, HY;Lin, KM;Liu, SC;Kuo, HW;Chiang, IC;Chen, AC;Tian, JN;Liu, YL
國家衛生研究院	2012-09-25	A pilot randomized controlled trial to improve geriatric frailty	Chan, DC;Tsou, HH;Yang, RS;Tsauo, JY;Chen, CY;Hsiung, CA;Kuo, K
國家衛生研究院	2012-09-04	Assessment of regional treatment effect in a multiregional clinical trial	Tsong, Y;Chang, WJ;Dong, X;Tsou, HH
國家衛生研究院	2012-09	Putative tumor metastasis-associated genes in human gastric cancer	Tuan, TF;Chung, CT;Tsou, HH;Chen, FW;Lin, HL;Lai, YK;Lee, WS;Chao, YS;Hwang, LL;Chen, CT
國家衛生研究院	2012-09	Weighted evidence approach of bridging study	Tsou, HH;Tsong, Y;Liu, JT;Dong, XY;Wu, YT
國家衛生研究院	2012-09	Design and analysis issues of multiregional clinical trials with different regional primary endpoints	Tsou, HH;Tsong, Y;Chang, WJ;Dong, X;Hsiao, CF
國家衛生研究院	2012-07-26	Multiregional Clinical Trials	Tsong, Y;Tsou, HH
國家衛生研究院	2012-07-26	A bayesian approach for evaluation of bridging studies	Hsiao, CF;Tsou, HH;Liu, JP;Wu, YJ
國家衛生研究院	2012-07-26	Two-stage designs of bridging studies	Hsiao, CF;Tsou, HH;Liu, JP;Wu, YJ
國家衛生研究院	2012-07	Establishing consistency across all regions in a multi-regional clinical trial	Tsou, HH;James Hung, HM;Chen, YM;Huang, WS;Chang, WJ;Hsiao, CF
國家衛生研究院	2012-06	UGT2B7 genetic polymorphisms are associated with the withdrawal symptoms in methadone maintenance patients	Tian, JN;Ho, IK;Tsou, HH;Fang, CP;Hsiao, CF;Chen, CH;Tan, HK;Lin, L;Wu, CS;Su, LW;Huang, CL;Yang, YH;Liu, ML;Chen, YT;Liu, SC;Hsu, YT;Kuo, HW;Liu, CT;Yang, YT;Chen, A;Shih, YH;Liu, YL
國家衛生研究院	2011-10	Genetic polymorphisms in CYP3A4 are associated with withdrawal symptoms and adverse reactions in methadone maintenance patients	Chen, CH;Wang, SC;Tsou, HH;Ho, IK;Tian, JN;Yu, CJ;Hsiao, CF;Chou, SY;Lin, YF;Fang, KC;Huang, CL;Su, LW;Fang, YC;Liu, ML;Lin, KM;Hsu, YT;Liu, SC;Chen, AC;Liu, YL
中國醫藥大學	2011-10	Genetic polymorphisms in CYP3A4 are associated with withdrawal symptoms and adverse reactions in methadone maintenance patients	(Chen CH);(Wang SC);(Tsou HH);(Ho IK);(Tian JN);(Yu CJ);(Hsiao CF);(Chou SY);(Lin YF);(Fang KC);黃介良(Chieh-Liang Huang);(Su LW);(Fang YC);(Liu ML);(Lin KM);(Hsu YT);(Liu SC);(Chen AC);(Liu YL)*
國家衛生研究院	2011-09-23	A phase II study of neoadjuvant bio-chemotherapy with Cetuximab, Paclitaxel, and Cisplatin (CPC) followed by Cetuximab-based concurrent bio-radiotherapy in high-risk locally advanced head and neck cancer - representative of head and neck cancer study grou	Chang, KY;Yen, CJ;Hsieh, CY;Tsou, HH;Chiu, CF;Chen, CC;Tsao, CJ;Tsai, KY;Tsai, ST;Chang, JY
國家衛生研究院	2011-08	CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S-enantiomer	Wang, SC;Ho, IK;Tsou, HH;Tian, JN;Hsiao, CF;Chen, CH;Tan, HK;Lin, L;Wu, CS;Su, LW;Huang, CL;Yang, YH;Liu, ML;Lin, KM;Chen, CY;Liu, SC;Wu, HY;Chan, HW;Tsai, MH;Lin, PS;Liu, YL
中國醫藥大學	2011-08	CYP2B6 Polymorphisms Influence the Plasma Concentration and Clearance of the Methadone S-Enantiomer	(Wang SC);(Ho IK);(Tsou HH);(Tian JN);(Hsiao CF);(Chen CH);(Tan HK);(Lin L);(Wu CS);(Su LW);黃介良(Chieh-Liang Huang);(Yang YH);(Liu ML);(Lin KM);(Chen CY);(Liu SC);(Wu HY);(Chan HW);(sai MH);(Lin PS);(Liu YL)*

显示项目 41-90 / 109 (共3页)
1 2 3 > >>
每页显示[10|25|50]项目

	English \| 正體中文 \| 简体中文 \| 总笔数 :2832487
	造访人次 : 33866535 在线人数 : 1361 教育部委托研究计画计画执行:国立台湾大学图书馆